Investing Profile

Andrew Schiff

VC
Photo of Andrew Schiff, Managing Partner at Aisling Capital

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
cb
Aisling Capital Managing Partner
14
$280M
CompanyStageDateRound SizeTotal Raised
Forge Biologics
Series CSep 2022$90M
$250M
Co-investors: Chris Garabedian (Perceptive Advisors), Molly McCartin (Drive Capital)
Dren Bio
Series BJun 2022$65M
$130M
Co-investors: Rajeev Dadoo (SR One), Chandra Leo (HBM Partners AG)
Plant Culture Systems
Pre SeedApr 2021$500K
$500K
Co-investors: Marcy Simon
Monte Rosa Therapeutics
Series BSep 2020$96M
$220M
Co-investors: Ali Behbahani (New Enterprise Associates (NEA)), David Schenkein (GV (Google Ventures)), Issi Rozen (GV (Google Ventures)), Markus Warmuth (Versant Ventures), Alexander Mayweg (Versant Ventures), Chandra Leo (HBM Partners AG)
Zavante Therapeutics
Series AMar 2016$45M
$45M
Co-investors: Patrick Heron (Frazier Healthcare Partners)
Agile Therapeutics
Post Ipo EquityFeb 2015$20M
Series CJul 2012$40M
$110M
Co-investors: Karen Hong (Novo Ventures), Stacey Seltzer (Aisling Capital)
Miramar Labs
Series DOct 2014$26M
$46M
Co-investors: Hank Plain (Morgenthaler Ventures)
Zeltiq Aesthetics
Series DJun 2010$25M
$50M
Co-investors: Bryan Roberts (Venrock)